DeutschNewstral
Article
The Hindu on 2021-06-04 17:42
Serum Institute gets DCGI nod to make Sputnik V in India
Related news
- Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccineThe Hindu
- Oxford vaccine: DCGI directs Serum Institute of India to suspend recruitment for trialsThe Hindu
Serum gets DCGI nod for Phase 2 & 3 trialsThe Times of India- Coronavirus live updates | After Pfizer, Serum Institute seeks emergency use nod for Covishield in IndiaThe Hindu
India’s Serum Institute to make Russia’s Sputnik V vaccinePolitico.eu- Coronavirus | Serum Institute seeks emergency use nod for Covishield in IndiaThe Hindu
- MSerum Institute for Prioritizing Indiamvtelegraph.com
- Serum Institute of India to focus on supplying COVID-19 vaccine to India firstThe Hindu
- Never exported vaccines at the cost of people of India, says Serum Institute of IndiaThe Hindu
- 5 dead after major fire hits Serum Institute of India plant in PuneThe Hindu
- COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR, Serum Institute of IndiaThe Hindu
- Serum Institute of India set to invest £240 million in U.K.The Hindu
Serum Institute Of India Acquires 50 Percent Stake In Pharma Packaging Firm Schott Kaishatntribune.com- No new govt order, Covishield output to be cut by 50%: Serum Institute of IndiaThe Times of India
- Serum Institute puts India trials of Oxford's Covid vaccine on holdThe Times of India
- Coronavirus | Serum Institute of India stocking emergency doses of COVID-19 vaccineThe Hindu
Serum Institute of India could resume vaccine exports by June if local coronavirus cases subsideSouth China Morning Post- Dr. Reddy’s, RDIF get DCGI nod for Sputnik V clinical trialThe Hindu